Health Canada inspection
OPTILAB Montréal CHU Sainte-Justine: Health Canada inspection of Mar 22, 2019
Health Canada · BLOOD · rating I
Key facts
| Establishment | OPTILAB Montréal CHU Sainte-Justine |
|---|---|
| City | Montréal |
| Province | Quebec |
| Country | Canada |
| Program | BLOOD |
| Start date | Mar 18, 2019 |
| End date | Mar 22, 2019 |
| Rating | I |
| Rating description | Inspection in progress |
| Licence number | Not applicable |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: